- Home
- OPK vs BCSF Comparison
OPK vs BCSF Comparison
Compare OPK & BCSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OPK | BCSF |
|---|---|---|
| Founded | 2007 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 901.0M |
| IPO Year | 1995 | 2018 |
Fundamental Metrics
Financial Performance| Metric | OPK | BCSF |
|---|---|---|
| Price | $1.36 | $13.52 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $2.28 | ★ $15.50 |
| AVG Volume (30 Days) | ★ 4.1M | 448.3K |
| Earning Date | 02-26-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 12.84% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.44 |
| Revenue | ★ $642,067,000.00 | $278,347,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $9.75 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.11 | $13.20 |
| 52 Week High | $2.04 | $19.21 |
Technical Indicators
Market Signals| Indicator | OPK | BCSF |
|---|---|---|
| Relative Strength Index (RSI) | 57.15 | 37.92 |
| Support Level | $1.24 | $13.77 |
| Resistance Level | $1.33 | $14.35 |
| Average True Range (ATR) | 0.05 | 0.27 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 92.31 | 2.35 |
Price Performance
Historical ComparisonAbout OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
About BCSF Bain Capital Specialty Finance Inc.
Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing predominantly in middle-market companies with between $10.0 million and $150.0 million in annual EBITDA. Its portfolio of investments includes First Lien Senior Secured Loan, Preferred Equity, Equity Interest, Warrants, and Second Lien Senior Secured Loan among others.